Who owns SYROS PHARMACEUTICALS INC?
- Ticker: SYRS
- CUSIP Number: 87184q206
Tip: Access positions for across all investors
Analyze quarterly positions in Syros Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Syros Pharmaceuticals stock
Who bought or sold SYROS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 2.8M | $632k | 0% | Dec 2024 |
|
| Siren | 2.6M | $5.6M | 100% | Sep 2024 |
|
| Affinity Asset Advisors | 1.7M | $389k | 37% | Dec 2024 |
|
| Deep Track Capital | 829k | $1.8M | 0% | Sep 2024 |
|
| Blue Owl Capital Holdings | 516k | $1.1M | 51% | Sep 2024 |
|
| Exome Asset Management | 299k | $642k | 88% | Sep 2024 |
|
| BlackRock | 277k | $64k | 6% | Dec 2024 |
|
| Vanguard Group | 268k | $62k | -72% | Dec 2024 |
|
| Omega Fund Management | 251k | $58k | 0% | Dec 2024 |
|
| Acadian Asset Management | 249k | $55k | 372% | Dec 2024 |
|
| Citadel Advisors | 212k | $49k | 173% | Dec 2024 |
|
| Geode Capital Management | 196k | $45k | -4% | Dec 2024 |
|
| Citigroup | 139k | $32k | 20166% | Dec 2024 |
|
| Qube Research & Technologies | 122k | $28k | 57% | Dec 2024 |
|
| Two Sigma Securities | 108k | $25k | 100% | Dec 2024 |
|
| Renaissance Technologies | 96k | $22k | 0% | Dec 2024 |
|
| Hrt Financial | 88k | $20k | 100% | Dec 2024 |
|
| XTX Topco | 82k | $19k | 183% | Dec 2024 |
|
| State Street Corporation | 69k | $16k | 0% | Dec 2024 |
|
| Jane Street | 53k | $12k | 100% | Dec 2024 |
|
| Two Sigma Investments | 49k | $11k | 72% | Dec 2024 |
|
| UBS Group | 45k | $11k | 169% | Dec 2024 |
|
| ADAR1 Capital Management | 45k | $97k | 100% | Sep 2024 |
|
| Northern Trust | 41k | $12k | 0% | Dec 2024 |
|
| 1492 Capital Management | 39k | $9.0k | 0% | Dec 2024 |
|
| Virtu Financial | 33k | $8.0k | 67% | Dec 2024 |
|
| Baader Bank | 22k | $4.5k | 100% | Dec 2024 |
|
| Clarius | 19k | $4.3k | 0% | Dec 2024 |
|
| HighTower Advisors | 15k | $3.4k | 0% | Dec 2024 |
|
| Susquehanna International | 14k | $3.2k | -75% | Dec 2024 |
|
| CI Private Wealth | 12k | $2.8k | 0% | Dec 2024 |
|
| Centerpoint Advisors | 11k | $2.0k | 0% | Dec 2024 |
|
| FNY Investment Advisers | 5.2k | $1.0k | 6773% | Dec 2024 |
|
| Federation des caisses Desjardins du Quebec | 4.5k | $9.7k | 0% | Sep 2024 |
|
| Tower Research Capital | 3.6k | $835.032900 | 1375% | Dec 2024 |
|
| Group One Trading | 3.4k | $770.979000 | -56% | Dec 2024 |
|
| SBI Securities | 1.9k | $433.090000 | 100% | Dec 2024 |
|
| Morgan Stanley | 1.7k | $387.656800 | -30% | Dec 2024 |
|
| Pnc Financial Services | 1.1k | $251.959500 | 0% | Dec 2024 |
|
| Advisor Group Holdings | 1.0k | $2.2k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 549.00 | $126.709200 | 0% | Dec 2024 |
|
| Wells Fargo & Company | 454.00 | $104.102200 | 0% | Dec 2024 |
|
| Bank of America Corporation | 212.00 | $47.912000 | -70% | Dec 2024 |
|
| Activest Wealth Management | 87.00 | $20.001300 | 0% | Dec 2024 |
|
| Sound Income Strategies | 76.00 | $17.001200 | 0% | Dec 2024 |
|
| PSI Advisors | 13.00 | $3.000400 | 0% | Dec 2024 |
|
| Truvestments Capital | 10.00 | $2.000000 | 100% | Dec 2024 |
|
| Steward Partners Investment Advisory | 8.00 | $2.000000 | 0% | Dec 2024 |
|
| FMR | 2.00 | $0 | 0% | Dec 2024 |
|
Who sold out of Syros Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Adage Capital Partners GP | Sep 2024 | 2.1M | $4.5M |
| Samsara BioCapital | Sep 2024 | 1.8M | $3.8M |
| Point72 Asset Management | Sep 2024 | 1.5M | $3.2M |
| Flagship Ventures Management | Sep 2024 | 1.3M | $2.8M |
| Avidity Partners Management | Sep 2024 | 1.1M | $2.3M |
| Opaleye Management | Sep 2024 | 655k | $1.4M |
| UBS O'Connor | Sep 2024 | 472k | $272k |
| ExodusPoint Capital Management | Sep 2024 | 313k | $673k |
| Marshall Wace | Sep 2024 | 160k | $345k |
| Perceptive Advisors | Sep 2024 | 117k | $251k |
| Springbok Capital Management | Sep 2024 | 89k | $192k |
| Walleye Trading Advisors | Sep 2024 | 87k | $186k |
| Bridgeway Capital Management | Sep 2024 | 52k | $111k |
| Pale Fire Capital SE | Sep 2024 | 49k | $106k |
| Superstring Capital Management | Jun 2024 | 38k | $195k |
| Millennium Management | Sep 2024 | 32k | $68k |
| Camden Capital | Sep 2024 | 30k | $64k |
| T. Rowe Price Associates | Sep 2024 | 23k | $49k |
| GSA Capital Partners | Sep 2024 | 16k | $34k |
| Wiser Wealth Management | Sep 2024 | 10k | $22k |
| Integrated Wealth Concepts | Sep 2024 | 10k | $22k |
| Royal Bank of Canada | Sep 2024 | 1.1k | $2.0k |
| National Bank Of Canada /fi/ | Jun 2024 | 859.00 | $4.2k |
| Russell Investments | Sep 2024 | 750.00 | $1.6k |
| Cubist Systematic Strategies | Sep 2024 | 595.00 | $1.3k |
| Fifth Third Bancorp | Sep 2024 | 129.00 | $277.001700 |